pendolmycin has been researched along with indolactam v in 2 studies
| Studies (pendolmycin) | Trials (pendolmycin) | Recent Studies (post-2010) (pendolmycin) | Studies (indolactam v) | Trials (indolactam v) | Recent Studies (post-2010) (indolactam v) |
|---|---|---|---|---|---|
| 6 | 0 | 4 | 94 | 0 | 21 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Billingsley, KL; Leister, J; Malepeai-Tofaeono, T; Mendoza, M; Ondrus, AE; To, K; Tran, U; Zhang, GC | 1 |
| Fujiki, H; Furuya-Suguri, H; Muratake, H; Nakayasu, M; Natsume, M; Nishiwaki, S; Okabe, K; Okabe, S; Suganuma, M; Yoshizawa, S | 1 |
2 other study(ies) available for pendolmycin and indolactam v
| Article | Year |
|---|---|
Indolactam Dipeptides as Nanomolar Gli Inhibitors.
Topics: | 2022 |
Pendolmycin, a new tumor promoter of the teleocidin A class on skin of CD-1 mice.
Topics: Alkaloids; Animals; Carcinogens; Enzyme Activation; Female; Indoles; Lactams; Lyngbya Toxins; Mice; Mice, Inbred Strains; Protein Kinase C; Skin; Skin Neoplasms; Structure-Activity Relationship; Tetradecanoylphorbol Acetate; Tritium | 1991 |